LINC01235

Across TCGA pan-cancer cohorts, LINC01235 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated LINC01235 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher LINC01235 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01235 expression acts as an unfavorable survival marker, although some lineages such as KIRC and SKCM show a favorable association.

BRCA, STAD, and CESC are the cancer types where LINC01235 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	II,III,IV	0.436	0.619	.001	100	view →
STAD	OS	Median	All	0.319	0.535	<.001	72	view →
CESC	OS	Quartile	All	0.808	0.948	.004	56	view →
KIRC	OS	Tertile	All	0.918	0.828	.003	54	view →
LGG	OS	Median	All	0.727	0.885	<.001	39	view →
UCEC	OS	Median	All	0.600	0.755	<.001	36	view →
ACC	DFS	Tertile	IV	0.110	0.553	.001	35	view →
MESO	OS	Median	II,III,IV	0.299	0.492	.003	26	view →
LUAD	OS	Median	All	0.319	0.413	.011	22	view →
KICH	DFS	Tertile	III,IV	0.386	1.000	.004	21	view →
KIRP	OS	Median	III,IV	0.404	0.914	.008	20	view →
BLCA	OS	Quartile	All	0.396	0.731	.005	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

LINC01235–BRCA (OS)

Open the BRCA breakdown →